Skip to main content

Animations

MJFF Publications

5601 - 5610 of 8587 Results
Title
Year
  • Year
  • 2016
  • 2011
  • 2024
  • 2018
  • 2023
  • 2020
  • 2018
  • 2024
  • 2012
  • 2018
  • Summary Details
    RESTRICTED
    Title: Monoamine transporter contributions to l-DOPA effects in hemi-parkinsonian rats
    Journal Name: Neuropharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuropharm.2016.07.025
    Best OA location URL:
    Citation Count: 26
  • Summary Details
    OPEN
    Title: Lrrk2 p.Q1111H substitution and Parkinson’s disease in Latin America
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2011.05.003
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Understanding what aspects of Parkinson’s disease matter most to patients and families
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41598-024-71555-4
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapy
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-018-0245-9
    Citation Count: 65
  • Summary Details
    RESTRICTED
    Title: Protective Effects of Lovastatin in a Population‐BasedALSStudy and Mouse Model
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/ana.26600
    Best OA location URL:
    Citation Count: 5
  • Summary Details
    RESTRICTED
    Title: PPMI 2.O New Science/New Cohorts - Transforming PPMI (2490)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.2490
    Best OA location URL:
    Citation Count: 7
  • Summary Details
    RESTRICTED
    Title: PDE10A and ADCY5 mutations linked to molecular and microstructural basal ganglia pathology
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27523
    Best OA location URL:
    Citation Count: 43
  • Summary Details
    RESTRICTED
    Title: What Parkinson's disease patients say in their own words about their mood and anxiety symptoms
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.107190
    Best OA location URL:
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Singing in groups for Parkinson's disease (SING-PD): A pilot study of group singing therapy for PD-related voice/speech disorders
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2012.02.009
    Best OA location URL:
    Citation Count: 65
  • Summary Details
    OPEN
    Title: Neuromodulation targets pathological not physiological beta bursts during gait in Parkinson's disease
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2018.09.004
    Best OA location URL:
    Citation Count: 125
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.